Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1989-10-12
|
pubmed:abstractText |
Of 140 patients with "scleroderma renal crisis" encountered during a 33-year period, 15 of 131 (11%) whose blood pressures were recorded were normotensive during this complication. In comparison with 116 patients with hypertension, the normotensive patients significantly more often had microangiopathic hemolytic anemia (90% versus 38%) and thrombocytopenia (83% versus 21%). Pulmonary hemorrhage occurred in 6 normotensive patients. More normotensive patients had received high doses of corticosteroids (prednisone greater than or equal to 30 mg/day) during the 2 months immediately preceding renal crisis (64% versus 16%). A role for corticosteroids in precipitating renal crisis is suggested. The 12-month survival was significantly reduced in the normotensive patients (13% versus 35%).
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0004-3591
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1128-34
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2775321-Acute Kidney Injury,
pubmed-meshheading:2775321-Blood Pressure,
pubmed-meshheading:2775321-Humans,
pubmed-meshheading:2775321-Hypertension,
pubmed-meshheading:2775321-Kidney,
pubmed-meshheading:2775321-Prednisone,
pubmed-meshheading:2775321-Prospective Studies,
pubmed-meshheading:2775321-Retrospective Studies,
pubmed-meshheading:2775321-Scleroderma, Systemic,
pubmed-meshheading:2775321-Skin
|
pubmed:year |
1989
|
pubmed:articleTitle |
Normotensive renal failure in systemic sclerosis.
|
pubmed:affiliation |
Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania 15261.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|